Work

Belatacept Is Associated with Improved Cardiovascular and Metabolic Risk Factors Compared to Cyclosporine in Kidney Transplant Patients (BENEFIT and BENEFIT-EXT Studies)

FWCI:
Cites:
Cited by: 1
Related to: 9